Mental health outcomes after SARS-CoV-2 vaccination in the United States: A national cross-sectional study.
Aruldass, Athina R
Cardinal, Rudolf N
Journal of Affective Disorders
MetadataShow full item record
Chen, S., Aruldass, A. R., & Cardinal, R. N. (2022). Mental health outcomes after SARS-CoV-2 vaccination in the United States: A national cross-sectional study.. Journal of Affective Disorders, 298 (Pt A), 396-399. https://doi.org/10.1016/j.jad.2021.10.134
Funder: NIHR Cambridge Biomedical Research Centre
Funder: National Institute for Health Research (NIHR)
BACKGROUND: Worsening of anxiety and depressive symptoms have been widely described during the COVID-19 pandemic. It can be hypothesized that vaccination could link to reduced symptoms of anxiety and/or depression. However, to date, no study has assessed this. This study aims to examine anxiety and depressive symptoms after vaccination in US adults, meanwhile test sociodemographic disparities in these outcomes. METHODS: Data from the January 6-June 7 2021, cross-sectional Household Pulse Survey were analyzed. Using survey-weighted logistic regression, we assessed the relationships between SARS-CoV-2 vaccination and anxiety and/or depressive symptoms, both on overall and sociodemographic subgroups. We controlled for a variety of potential socioeconomic and demographic confounding factors. RESULTS: Of the 453,167 participants studied, 52.2% of the participants had received the COVID-19 vaccine, and 26.5% and 20.3% of the participants reported anxiety and depression, respectively. Compared to those not vaccinated, the vaccinated participants had a 13% lower odds of anxiety (adjusted odds ratio [AOR] = 0.85, 95%CI 0.83-0.90) and 17% lower odds of depression (AOR = 0.83, 95%CI 0.79-0.85). Disparities on the above associations were identified in age, marital status, education level, ethnic/race, and income level, but not on gender. LIMITATIONS: The causal inference was not able to be investigated due to the cross-sectional study design. CONCLUSION: Being vaccinated for SARS-CoV-2 was associated with lower odds of anxiety and/or depressive symptoms. While those more middle-aged or more affluent, were more likely to show these negative associations, the contrary was observed in ethnic minorities and those with lower educational attainment. More strategic and demography-sensitive public health communications could perhaps temper these issues.
Anxiety, Depression, SARS-CoV-2 vaccination, United States
Medical Research Council (MC_PC_17213)
External DOI: https://doi.org/10.1016/j.jad.2021.10.134
This record's URL: https://www.repository.cam.ac.uk/handle/1810/332323
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: firstname.lastname@example.org